9 1ai

9+1AI is a digital health company pioneering FDA Breakthrough-designated artificial intelligence diagnostics for cardiovascular care. Our flagship innovation uses advanced ECG-AI for earlier detection of heart failure and unlocking new opportunities for preventive care. Spun out of the University of Tennessee Research Foundation and Wake Forest School of Medicine, we are building the HeartSight Library—an expanding portfolio of AI algorithms designed to detect and monitor over 18 cardiovascular and systemic conditions from a simple ECG. Our vision is to reimagine the ECG as a universal diagnostic platform—bringing biomarker-level precision to clinical, telehealth, and wearable environments worldwide.